Join the Dornsife COVID-19 Journal Club for a discussion of the paper “Dexamethasone in Hospitalized Patients with COVID-19 – Preliminary Report”, by the RECOVERY Collaborative Group, led by Michael LeVasseur, PhD, MPH, visiting assistant professor of epidemiology and biostatistics at Dornsife.

 

This paper was published in NEJM on July 17, 2020.  The paper describes a controlled, open-label trial of oral or intravenous dexamethasone (6 mg/once per day) for up to 10 days (2,104 patients) or usual care alone (4,321 patients).

Drexel staff, faculty and students are welcome to take part in this discussion.

 

> Zoom Access Link